Welcome to
Thera4Care
Theranostics Ecosystem for Personalised Care
About
Thera4Care was born out of a shared vision to transform cancer treatment through the power of radiotheranostics - a field that combines precise diagnostic imaging with targeted therapy. Recognising the limitations in conventional cancer treatments, Thera4Care was established by a team of leading scientists, healthcare professionals, and industry experts across Europe. Together, we aim to bridge the gap between innovative science and clinical practice, making personalised cancer care accessible to patients. With a commitment to advancing healthcare, Thera4Care seeks to bring new hope to those battling challenging cancers by focusing on precision, safety, and patient-centred solutions.
Our vision is to make personalised radiotheranostics an integral part of cancer care across Europe and beyond. We believe that every patient deserves access to the most effective, individualised treatment options available. To achieve this, we are building a sustainable network that not only advances medical innovation but also supports healthcare systems through enhanced manufacturing, digital platforms, and professional training. Thera4Care is dedicated to pioneering advancements in treatment precision, expanding the availability of essential resources, and ultimately improving the quality of life for cancer patients. By bringing our vision to life, we are moving closer to a future where cancer treatment is as unique as each patient.
Our Objectives
Diagnostic Innovation
Develop cutting-edge diagnostic tools that allow for earlier and more accurate detection of challenging cancers. By advancing our radiotheranostic capabilities, we aim to offer clinicians powerful insights that lead to better, personalised treatment plans for each patient.
Therapeutic Precision
Deliver targeted radiotheranostic therapies that are tailored to each patient’s unique needs. Our therapies focus on precision, minimising side effects and maximising effectiveness to improve overall patient outcomes in oncology care.
Data-driven insights
Harness data science and artificial intelligence to improve decision-making in cancer treatment. Our digital platform provides real-time insights that help healthcare professionals select the best treatment options, monitor patient progress, and adapt strategies based on individual needs.
Sustainability Supply Chain
Build a reliable, scalable supply chain for critical radiotheranostic resources, ensuring that healthcare providers across Europe have consistent access to essential materials. By supporting a robust infrastructure, we enable long-term sustainability in radiotheranostic services.
Knowledge Sharing & Training
Empower healthcare professionals through comprehensive education and training resources. Our goal is to create a well-informed network of practitioners skilled in radiotheranostics, ensuring that new advancements in cancer treatment reach patients faster and more effectively.
Our
Impact
Enhanced Treatment Availability
Thera4Care aims to broaden the range of accessible theranostic treatments for solid tumours. Through preclinical development and rigorous clinical evaluations, the initiative seeks to validate and introduce novel radionuclide-targeted therapies, ensuring a broader spectrum of effective treatment options for patients.
Strengthened European Healthcare Resilience
Thera4Care is building a sustainable infrastructure for the production and distribution of radiotheranostic resources, ensuring a reliable supply chain for critical medical isotopes and related technologies. This resilience will enable European healthcare systems to become more self-sufficient and prepared to meet the growing demand for advanced cancer treatments.
Improved Cancer Outcomes
Thera4Care is committed to enhancing clinical outcomes for patients with various cancers, including sarcoma, glioblastoma, ovarian, pancreatic, and neuroendocrine carcinomas. By leveraging advanced diagnostics and precision medicine AI, the initiative aims to significantly increase survival rates and improve the overall quality of life, contributing to the goals of Europe's Beating Cancer Plan.
.png)
Funding
Thera4Care is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101172788. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, EuropaBio, MedTech Europe, Vaccines Europe, Atley Solutions, Curasight, Dosisoft, Minerva Imaging, Perspective Therapeutics, and Terthera.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.
